Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Inc. (RCKT)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
2. 18
-0.18
-7.6271%
$
279.54M Market Cap
- P/E Ratio
- Div Yield
1.97M Volume
-3.06 Eps
$ 2.36
Previous Close
Add Transaction
Day Range
2.17 2.36
Year Range
2.17 5.45
Want to track RCKT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Rocket Pharmaceuticals Inc. (RCKT) Statistics

Valuation metrics

Market Cap 279.54M
Enterprise value 79.83M
Trailing P/E (ttm) -16
Forward P/E -
PEG ratio -0.11
Price/Sales (ttm) -
Price/Book (mrq) 0.78
Enterprise Value/Revenue -
Enterprise Value/EBITDA 13.75

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.48M
Average volume (90 days) 2.08M

Price summary

52-Week low 2.17
52-Week high 5.45
Beta -
50-Day moving average 2.56
200-Day moving average 3.44

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 5 Jan 2018

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -0.04%
Return on equity -0.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.15
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.51
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 9.24%
Book value per share (mrq) 3.27

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -